News for IRIDEX Corporation (IRIX)

Portage Biotech Inc (PRTG), a clinical stage immune-oncology company is up over 155 percent in Friday's pre-market trading. The following are some of the other stocks making big moves in Friday's pre-market trading.

Discover IRIDEX (IRIX) Q4 2024 earnings highlights: improved revenue, cost reductions, strategic investments, and growth opportunities for 2025.

IRIDEX Corporation (NASDAQ:IRIX) Q4 2024 Earnings Conference Call March 27, 2025 5:00 PM ETCompany ParticipantsTrip Taylor - Investor Relations...

MOUNTAIN VIEW, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation ( IRIX), a worldwide leader providing innovative and versatile laser-based medica

MOUNTAIN VIEW, Calif., March 19, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation ( IRIX), a worldwide leader providing innovative and versatile laser-based medica

Iridex (IRIX) Wednesday named Romeo Dizon as the company’s Chief Financial Officer, replacing Fuad Ahmad.

**media[570931]**

MOUNTAIN VIEW, Calif., March 14, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation ( IRIX), a worldwide leader providing innovative and versatile laser-based medica

MOUNTAIN VIEW, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation ( IRIX), a worldwide leader providing innovative and versatile laser-based medica

Iridex Corporation (IRIX) said it expects fourth quarter total revenue to be between $12.6 million and $12.7 million compared to $12.5 million in the prior year quarter.

Iridex (IRIX) reports slightly higher Q4 revenue and decrease in FY24 revenue.

**media[514517]**

IRIDEX Corporation (IRIX), a company specializing in laser medical systems and ophthalmic devices, experienced a significant stock price decline of 5.44%, falli

**media[470371]**

IRIDEX Corporation (NASDAQ:IRIX) Q3 2024 Earnings Call Transcript November 12, 2024 5:00 PM ETCompany ParticipantsScott Shuda - Executive ChairmanPatrick...

Iridex to Report Third Quarter 2024 Financial Results on November 12, 2024

The global medical laser market growth fueled by technological innovation, high prevalence of chronic conditions, and cosmetic procedures...

Iridex Corporation appoints Patrick Mercer as new CEO, with Scott Shuda as Executive Chairman. David Bruce transitions out.

IRIDEX faced delays in selling assets as part of a strategic review initiated a year ago, causing frustration among shareholders. Read my analysis of IRIX stock.